ClinicalTrials.govpublic full text
A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies
metastatic castration-resistant prostrate cancer, renal cell carcinoma, metastatic melanoma, non-small cell lung cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 871127
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.